Patent Grant
9034024
1. Field of the invention
The invention relates to the field of treatment for male and female reproductive varices, in particular for varicoceles in men and pelvic varices in women, and includes oesophageal varices.
2. Information Disclosure Statement
Varices are uneven, permanent dilations of veins than can occur in numerous areas of the body, and are very common in the superficial veins of the lower limbs (varicose, spider veins). One manifestation of these varices that occurs in men, and is the most common cause of male infertility, is the varicocele. Between 10 and 20% of post-pubescent males are affected by varicoceles, and 20-40% of all infertile males have varicoceles. A varicocele specifically refers to dilatation and tortuosity of the pampiniform plexus. Pampiniform plexus is the network of veins that drain the testicle. Plexus travels along the posterior part of the testicle with the epididymis and vas deferens, and then into the spermatic cord, which extends from the testes up through the ingiunal canal in the lower abdominal wall to the circulatory system. The vas deferens is not situated by itself but is a part of a larger tissue bundle called the spermatic cord. The spermatic cord contains many blood vessels as well as the vas deferens, nerves, and lymphatic channels. Hence care needs to be taken to avoid vas deferens and vessels to avoided permanent damage to testis.
A varicocele can develop in one or both testicles, but in most cases occurs in the left testicle. Because of the varicocele's impairment of blood flow, the blood cannot cool as it does in normal veins, and this increased temperature is thought to be a cause of infertility. The excess heat can damage sperm or impede the production of new healthy sperm.
Varices can also play a role in chronic pelvic pain syndrome in women. One of numerous causes of chronic pelvic pain in women is “pelvic congestion syndrome” (PCS), a condition in which varices form in the pelvis minor, affecting organs including the uterus, ovaries and vulva. PCS is analogous to varicoceles in men. Pelvic varices occur in around 10% of the female population, and varices occur usually in women of the ages of 20-50.
A variety of treatments have been attempted for female pelvic varices, with varying degrees of success. Medications, including vasoconstrictors and hormonal medications, have been used successfully, though they may not always provide long-term relief. Numerous surgical treatments have also been performed, including tying off or removing veins, uterine suspension, and, generally as a last resort, hysterectomy.
Numerous options are also available for treatment of male varicoceles. Surgical treatment, usually performed under general anesthetic, involves making an incision above the scrotum and tying off the veins to detour blood flow into normal veins. Such a procedure can require up to six weeks recovery time before heavy lifting can be performed, with light activities able to be performed earlier.
Embolization is a procedure used by surgeons to block fluid flow through a blood vessel or organ, and has been used to treat both male varicoceles and female pelvic varices with at least some success. An embolus, which is a mass of some material, is inserted into the blood vessel with a catheter and is lodged in the vessel to restrict blood or fluid flow. This causes a clot to develop in the vessel that closes off the vessel. Types of emboli include wire coils, sponges, “chemical cross-linking means such as cyanoacrylate”, balloons, umbrella-like devices and other types of plugs. (U.S. Pat. No. 5,167,624)
U.S. Pat. No. 4,509,504 discloses the use of a device consisting of a material that swells when in contact with body fluid. The device is inserted into a body passage and the material is swelled to occlude the passage. The passages could be blood vessels (including varicose veins), urethers, spermatic ducts and oviducts. The device can purportedly be used as a contraceptive. When swelled, the device anchors in position and fully occludes the passage.
U.S. Pat. No. 6,200,332 describes a device and method for underskin laser treatment. Indications such as wrinkles and varicose veins can be treated with this invention. The handpiece uses a standard needle to insert an optical fiber under the skin or into a blood vessel, and features an extension piece that maintains the end of the optical fiber in a fixed position relative to the handpiece. The method described in this invention is generally envisioned for the treatment of tissue near the surface of the skin, for cosmetic procedures such as surface varicose veins or wrinkle removal. It is not suitable for deep interior treatments such as varicoceles or pelvic varices because of the anatomical positions and function. Again because of the anatomical position of the vein care needs to be taken to avoid damages to renal arterial, like transection, intimal tears, or thrombotic occlusion
U.S. Pat. No. 5,167,624 describes a method and apparatus for passing an embolus into a blood vessel. The embolus lodges in the vessel and allows formation of a vessel-occluding clot around the embolus. The embolus is hydraulically passed through the lumen of a catheter to a given point in a blood vessel; the hydraulic fluid pushed the embolus to a predetermined position in the blood vessel. The embolus is preferably a coil that is stretched in the catheter lumen and recoils once released into the blood vessels. The recoiling causes the spring to expand and exert a force on the wall of the blood vessel to anchor it in place.
U.S. Application No. 2002/0156499 describes an apparatus and method featuring a deformable member for occluding a blood vessel. Upon application of force on the occluder, the occluder can be deformed to expand to fully occlude a vessel, and may further be anchored so that migration can be avoided.
WO 01/66016 A1 describes embolic particles, agents and compositions, visible by ultrasound, for embolization to treat various disorders such as varicocele. Microbubbles are incorporated into or around the particles to allow the particles or composition to visible by ultrasound, thus avoiding the need for fluoroscopy and contrast agents in angiography.
Embolization procedures are typically outpatient procedures that require 24 hours or less of recovery time. Disadvantages include the relative complexity of the inserted embolus and the associated delivery equipment and the increased risk of infection, migration, or other complications due to the need to deposit and secure a foreign body within the blood vessel.
WO2009109967A1 discloses a method for collapsing a target vein comprising providing an intravascular irritation element having mechanical irritating objects, inserting the intravascular irritation element into a venous lumen of a target vein, and irritating the target vein by moving mechanical irritating objects in contact with the inner surface triggering a collapse of said target vein. Irritating objects include a shape memory element having a regainable geometry, wherein the providing comprises providing the intravascular irritation element in a collapsed state and the irritating comprises allowing the shape memory element to expand toward the regainable geometry in the venous lumen. Optionally, the irritating comprises rotating the intravascular irritation element around a longitudinal axis of the target lumen or brushing irritation element against the inner surface in a helical pattern. Inserting comprises releasing a sclerosing agent in proximity to the inner surface or withdrawing blood in proximity to the inner surface. Causing vein collapse by mechanical irritation lacks effectiveness and is often only a temporary benefit.
Most of the procedures discussed in the prior art use invasive methods. Since varicoceles in men and pelvic varices in women are known to involve the reproductive organs extra care needs to be taken since most patients affected are in reproductive age group. The Pampiniform plexus in the testis and pelvis minor in pelvic regions, which are affected by varices are connected to other major veins, which are again connected to other vital organs in the abdominal cavity, and are surrounded by other major arteries and nerves in the regions, hence utmost care needs to be taken while accessing this vein unlike the veins in the legs. Any damage to the other veins or artery can cause significant, irreversible damage to reproductive organs.
In prior art cases the vein closure is not complete because collateral veins running parallel to testicular vein are missed, and recurrence is common. Collateral veins are difficult to identify and ligate separately from the testicular artery. Similarly access to the right internal spermatic vein is very difficult and requires significant time.
Other disadvantages include long duration of the procedure, Seduction, failure to access the internal spermatic vein, radiation exposure and recurrent varicocele. And most importantly the success of these procedures is clearly dependent upon a high level of skill and experience of the interventional radiologist.
There remains a need for a minimally invasive treatment of varicocele and other delicately placed abnormal veins that does not require the permanent or extended insertion of foreign objects and can be performed with a minimum of pain and without significant recovery time. The present invention addresses these needs.
It is an object of the present invention to provide an improved method for treatment of varices.
It is another object of the present invention to provide a method for treatment of varices, particularly pelvic varices, varicoceles and oesophageal varices that is minimally invasive, does not require general anesthesia, and requires little or no time for patient recovery.
It is still another object of the present invention to provide a method for treatment of pelvic varices, varicoceles, and oesophageal varices that does not require the deposition of foreign objects in the body.
It is yet another object of the present invention to provide a method for treatment of pelvic varices, varicoceles, and oesophageal varices that renders optimal effective energy emission and absorption to achieve permanent vein closure.
Briefly stated, the present invention discloses a minimally invasive method for treating varices in especially sensitive areas, including pelvic varices in females, varicoceles, and also oesophageal varices. The method comprises the steps of making a micro incision into the blood vessels of a patient, endoscopically inserting a catheter device into the blood vessel of a patient and advancing the distal end of the catheter to reach the varix or varices. For treatment of male varicocele, insertion is preferably made directly at the testicle. Alternatively, insertion can be made in the femoral vein and advanced using a catheter. Preferably, x-ray, angiography, or other imaging techniques are used to visualize and position the catheter. An optical fiber is then inserted into the catheter and the distal end is advanced to a predetermined point near the varix or varices. Optical fiber distal end is preferably a slim, radial 360 degree emitting fiber end. Laser energy of preferably 1470±30 nm is then transmitted to the varix to close the blood vessel. Other wavelengths with similar or greater absorption in blood/water than at 1470 nm are also effective. Imaging techniques such as angiographies may again be performed to confirm closure of the vein. The laser source linked to a radial emitting fiber allows for thermo occlusion of varicoceles using about 2-3 W of emitting power with little or no pain or discomfort for patient. The present invention is an out-patient procedure that requires no anesthesia and minimal recovery time, and does not require that any foreign objects be left in the body. This method has been shown to have a high success rate and minimum pain or side effects for the patient.
The above, and other objects, features and advantages of the present invention will become apparent from the following description read in conjunction with the accompanying drawings.
FIG. 1—Illustration of a preferred method for treatment of a varicocele.
FIG. 2—Illustration of another preferred the method for treatment of a varicocele.
FIG. 3—Absorption spectra of water and blood around 1470 nm.
FIG. 4—Graph of measured temperatures at the radial fiber tip, immersed in water, using 1470 nm laser radiation at different power levels.
US Patent publication 2007/0100329A1 to Maglione et al which is also assigned to the assignee of the present invention, and is hereby incorporated by reference in its entirety as part of the present disclosure, as noted in the priority section, relates to a method which comprises the steps of inserting a catheter device into the blood vessels of a patient and advancing the distal end of the catheter to reach the varix or varices using proper imaging techniques to visualize and position the catheter. The insertion is preferably made in the femoral vein. A bare tip or diffusing tip optical fiber is then inserted into the catheter and the distal end is advanced to a predetermined point near the varix or varices. In this earlier approach, laser energy of 980 nm is transmitted to the varix to close the blood vessel. Imaging techniques such as angiographies are then performed to confirm closure of the vein. It is an out-patient procedure that requires no incision or general anesthesia, requires minimal recovery time, and does not require that any foreign objects be left in the body. This invention still has room for improvement. Disclosed optical fiber tip configurations may at times lack effectiveness. Furthermore, suggested 980 nm wavelength is well absorbed by hemoglobin but less absorbed by water, largely present in target vein. Additionally, smaller emission power is permanently sought by those skilled in the art to lower potential collateral effects to a minimum. Finally, recent experience revealed that continuous emission mode offers better results over pulsed emission modes when it comes to permanent vessel ablation.
The present invention is a method for treating male and female varices located in or near the reproductive system. Due to their anatomical location within the body it is considered to be delicate when compared to leg veins and their treatment methods. Moreover the affected veins are connected to other veins which in turn are connected to vital organs in that region, hence this vein needs to be carefully treated to avoid irreversible damage to these organs and their function.
In particular, the method is effective for treating varicoceles in men and pelvic varices in women. It is an outpatient procedure performed under local anesthetics, it can be quickly performed with a minimum of recovery time, and avoids the need to introduce foreign objects into the body, in contrast to traditional embolization treatments.
A small catheter is inserted into the circulatory system either at the groin, preferably into the femoral vein, or in the case of male varicocele, through more direct percutaneous access above the scrotum at the base of the penis by making a small painless incision. Preferably under X-ray imaging, the catheter is moved into position near the varicocele vein mass. Optionally, further visualization procedures such as angiographies with contrast (dye), may be performed to achieve correct positioning.
After the catheter is correctly positioned, a laser fiber is inserted into the catheter and secured to the catheter by a special locking system so that the distal end of the fiber extends a preselected distance from the distal part of the catheter itself. An exemplary embodiment of a locking system for use with the present invention is described in U.S. Pat. No. 6,200,332. This patent describes an underskin laser treatment device comprising a handpiece having a hollow channel and fitted with a hollow surgical needle through which an optical fiber, connected to a laser source, is inserted. The handpiece farther comprises an extension that can fit into the hollow channel having a protrusion which is keyed to a groove within the channel wall for guiding the optical fiber through the handpiece and needle. This device, by virtue of the extension piece, maintains the optical fiber in a fixed position relative to, and at a fixed distance from, the handpiece, allowing the user to know how much of the fiber has been inserted into the treatment area.
Laser energy having a wavelength of preferably 1470 nm is then delivered following a preselected radiation protocol of parameters, which may vary according to patient. Such protocol parameters include emission mode and emitted power. Preferably, settings are 2-3 Watts in continuous mode. Ideal pullback speed is approximately 0.25 cm per second.
Following irradiation, the catheter and fiber are withdrawn together until their ends reach the proximal part of the varicocele vein. The fiber is withdrawn through the catheter and dye may be injected so that further angiographies can be performed to confirm the closure of the vein. Other visualization techniques, such as echo color Doppler ultrasound, may also be used.
Radiation is preferably delivered through a 400 μm, 360 radially emitting optical fiber, such as the one described in US Published Application, 2009/0240242 to Neuberger. A preferred radiation source is a 4 Watt diode laser or diode array emitting at a wavelength of 1470 nm. The optical fiber is connected to the radiation source at its proximal end and its distal end contains a means for distributing radiation. This radiation distribution means may take a variety of forms, preferably a 360 degree radial emitting distal end or alternatively a diffuser end is used. Laser energy, especially in the range of 1470 nm, is optimal for effecting vein closure by causing the vein wall to shrink and close off the vein, due to this wavelength's extremely high absorption by water. Damage to the vein wall creates a shrinking effect that acts to close from the vessel. The presence of blood in the vein plays a key role in evenly distributing thermal damage to the inner vein wall and creating damage over a wide inner surface area of the vein wall, and thus helps to more efficiently create a thrombotic occlusion and avoids simply cutting through the vein wall. This mechanism for closing the vein aids the collapse of the vessel wall due to the 1470 nm wavelength's high absorption in water within the blood. Additionally, the radiation can also have a coagulating effect on the blood, which can also aid in closing off or blocking the vein. Finally, radial emission greatly contributes to a fast and uniform radiation of vein walls. These effects may act in conjunction to cause effective closure of the vein.
An advantage of the present invention is that a foreign body need not be inserted into the vein to trigger embolization. Because of this, there is no need for a mechanism to push the embolus into the vein, which simplifies both the procedure and the equipment needed. In addition, because no foreign body is left in the vein after treatment, the present invention does not introduce the risk of infection present in traditional embolization techniques. Also, the risk of migration, inherent in many detached occluding devices, is eliminated with the present invention.
There are numerous additional advantages of the present invention over prior art treatments. The method of the present invention does not require more than a small incision (only large enough to insert the small catheter), resulting in faster recovery and no damage to other vessels or organs and no scaring. Each of these improvements is significant to the well being of the patients. The use of general anesthetics can be avoided. Data show higher success rate then embolization. Lastly, little or no recovery time is required and patients can resume activities faster than after normal surgery.
A preferred embodiment of the present invention is illustrated in
Another preferred embodiment of the present invention is illustrated in
The present invention is not merely limited to varicocele and female pelvic varices treatment. Oesophageal varices, which also are delicate and difficult to treat because of their placement, may also be treated successfully using the method of the present invention. Oesophageal varices are enlarged veins on the lining of the esophagus that are prone to bleeding. They are life-threatening, and can be fatal in up to 50% of patients. They usually appear in patients with severe liver disease. For treatment of this indication, the method of the present invention is similar to that described above for varicoceles and female pelvic varices. In this embodiment, the catheter is inserted into the portal vein and advanced to a point proximate to the varices. Radiation as indicated above is applied to close off the vein.
The present invention is further illustrated by the following example, where a wavelength more commonly associated with tissue ablation or cutting is successfully used, but is not limited thereby.
The present invention is very effective for treating varicoceles in the spermatic cord above the testicle. This example illustrates treatment of a varicocele above the left testicle of a patient. A catheter is inserted into the right femoral vein and advanced so that the distal end of the catheter is approximately 1 cm from the desired site of vein closure. X-ray imaging and angiography are performed to visualize this step and aid insertion. A 400 micron radial fiber is coupled to a 1470 nm diode laser, whose absorption in water and blood is nearly 100% as shown in
Having described preferred embodiments of the invention with reference to the accompanying drawings, it is to be understood that the invention is not limited to the precise embodiments, and that various changes and modifications may be effected therein by those skilled in the art without departing from the scope or spirit of the invention as defined in the appended claims.
This application is a continuation-in-part of U.S. patent application Ser. No. 11/637,377 filed on Dec. 12, 2006 now U.S. Pat. No. 8,257,411 by Maglione, Caldera, and Coluccia, inventors, entitled “Method for Treatment of Varices,” which is a continuation-in-part of U.S. patent application Ser. No. 10/675,461 filed on Sep. 30, 2003 now abandoned by Maglione, Caldera, Coluccia, inventors, entitled “Method for Treatment of Varices,” each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure.
| Number | Name | Date | Kind |
|---|---|---|---|
| 5188602 | Nichols | Feb 1993 | A |
| 6638273 | Farley et al. | Oct 2003 | B1 |
| 20050015123 | Paithankar | Jan 2005 | A1 |
| 20050070886 | Maglione et al. | Mar 2005 | A1 |
| Number | Date | Country | |
|---|---|---|---|
| 20110166561 A1 | Jul 2011 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 11637377 | Dec 2006 | US |
| Child | 12985602 | US | |
| Parent | 10675461 | Sep 2003 | US |
| Child | 11637377 | US |
